We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
- Authors
Aghajanian, Carol; Blank, Stephanie V; Goff, Barbara A; Judson, Patricia L; Teneriello, Michael G; Husain, Amreen; Sovak, Mika A; Yi, Jing; Nycum, Lawrence R
- Abstract
This randomized, multicenter, blinded, placebo-controlled phase III trial tested the efficacy and safety of bevacizumab (BV) with gemcitabine and carboplatin (GC) compared with GC in platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer (ROC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Vol 30, Issue 17, p2039
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2012.42.0505